Hope for patients with neuromyelitis optica spectrum disorders — from mechanisms to trials
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cellular and Molecular Neuroscience,Neurology (clinical)
Link
https://www.nature.com/articles/s41582-021-00568-8.pdf
Reference114 articles.
1. Lennon, V. A. et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364, 2106–2112 (2004). This paper reported the discovery of the NMO biomarker NMO-IgG.
2. Lennon, V. A., Kryzer, T. J., Pittock, S. J., Verkman, A. S. & Hinson, S. R. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J. Exp. Med. 202, 473–477 (2005). This paper reported that AQP4 is the antigenic target of NMO-IgG.
3. Wingerchuk, D. M. et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85, 177–189 (2015).
4. Wingerchuk, D. M., Hogancamp, W. F., O’Brien, P. C. & Weinshenker, B. G. The clinical course of neuromyelitis optica (Devic’s syndrome). Neurology 53, 1107–1114 (1999).
5. Wingerchuk, D. M., Lennon, V. A., Pittock, S. J., Lucchinetti, C. F. & Weinshenker, B. G. Revised diagnostic criteria for neuromyelitis optica. Neurology 66, 1485–1489 (2006).
Cited by 76 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Research progress in the mechanisms and functions of specialized pro-resolving mediators in neurological diseases;Prostaglandins & Other Lipid Mediators;2024-12
2. Clinical practice guidelines for multiple sclerosis, neuromyelitis optica spectrum disorder, and myelin oligodendrocyte glycoprotein antibody-associated disease 2023 in Japan;Multiple Sclerosis and Related Disorders;2024-10
3. NMOSD and MOGAD: an evolving disease spectrum;Nature Reviews Neurology;2024-09-13
4. Different Complement Activation Patterns Following C5 Cleavage in MOGAD and AQP4-IgG+NMOSD;Neurology Neuroimmunology & Neuroinflammation;2024-09
5. Visual improvement in a case of neuromyelitis optica spectrum disorder-related optic neuritis after 18 months of treatment with satralizumab: A case report;Heliyon;2024-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3